TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer

Citation:

Ntavatzikos A, Spathis A, Patapis P, Machairas N, Vourli G, Peros G, Papadopoulos I, Panayiotides I, Koumarianou A. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World Journal of Gastrointestinal Oncology [Internet]. 2019;11:551-566.

Notes:

cited By 7

Website

Contact Details

National and Kapodistrian University of Athens, University General Hospital 'Attikon', Fourth Surgery Department,
Mobile +30 6944 661 484

Athens, ZipCode 12462
ipapado@med.uoa.gr
ina.papadopoulos@gmail.com

<embed>

Recent Publications

Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients
Femoral fractures are an indicator of increased severity of injury for road traffic collision victims: an autopsy–based case–control study on 4895 fatalities
Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma

Submitted (1)
2021 (1)
2020 (5)
2019 (1)
2018 (5)
2017 (17)
2016 (4)
2015 (3)
2014 (20)
2013 (12)

Iordanis Papadopoulos

Professor, Medicine

TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer

Citation:

Notes:

Contact Details

Recent Publications

Publications per year